Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-22

Clinical Trial Update: BioPearl™ Microspheres Loaded With Doxorubicin for the Treatment of Unresectable Hepatocellular Carcinoma (HCC) [NA]

View source ↗

Summary

This clinical trial update notes that Terumo Europe N.V. is recruiting for a study of BioPearl microspheres loaded with doxorubicin to treat unresectable hepato…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioPearl microspheres loaded with doxorubicin (Doxorubicin)

Snippet

Sponsor: Terumo Europe N.V. | Conditions: Hepatocellular Carcinoma Non-resectable | NA | Status: RECRUITING